Catalyst Wire Dossier Catalyst Wire Dossier

Anti-VEGF agent

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-VEGF agent, covering 2010-06-22 to 2010-06-22. Get the full timeline:

Most recent: Clinical Trial Update: Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) [Phase 2]

See pricing